38 related articles for article (PubMed ID: 33142068)
1. Efficacy of single-dose cholecalciferol in the blood pressure of patients with type 2 diabetes, hypertension and hypovitaminoses D.
de Paula TP; Moreira JSR; Sperb LF; Muller MEP; Steemburgo T; Viana LV
Sci Rep; 2020 Nov; 10(1):19611. PubMed ID: 33184328
[TBL] [Abstract][Full Text] [Related]
2. Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical Trial.
Scott JG; Baker A; Lim CCW; Foley S; Dark F; Gordon A; Ward D; Richardson D; Bruxner G; Beckmann KM; Hatherill S; Stathis S; Dixon K; Ryan AE; McWhinney BC; Ungerer JPJ; Berk M; Dean OM; Saha S; McGrath J
JAMA Netw Open; 2020 Nov; 3(11):e2024335. PubMed ID: 33170261
[TBL] [Abstract][Full Text] [Related]
3. Correlations between microbiota and metabolites after faecal microbiota transfer in irritable bowel syndrome.
Holster S; Repsilber D; Geng D; Hyötyläinen T; Salonen A; Lindqvist CM; Rajan SK; de Vos WM; Brummer RJ; König J
Benef Microbes; 2021 Feb; 12(1):17-30. PubMed ID: 33350360
[TBL] [Abstract][Full Text] [Related]
4. Microscopic Colitis: A Concise Review for Clinicians.
Tome J; Kamboj AK; Pardi DS
Mayo Clin Proc; 2021 May; 96(5):1302-1308. PubMed ID: 33958059
[TBL] [Abstract][Full Text] [Related]
5. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.
Miehlke S; Guagnozzi D; Zabana Y; Tontini GE; Kanstrup Fiehn AM; Wildt S; Bohr J; Bonderup O; Bouma G; D'Amato M; Heiberg Engel PJ; Fernandez-Banares F; Macaigne G; Hjortswang H; Hultgren-Hörnquist E; Koulaouzidis A; Kupcinskas J; Landolfi S; Latella G; Lucendo A; Lyutakov I; Madisch A; Magro F; Marlicz W; Mihaly E; Munck LK; Ostvik AE; Patai ÁV; Penchev P; Skonieczna-Żydecka K; Verhaegh B; Münch A
United European Gastroenterol J; 2021 Feb; 9(1):13-37. PubMed ID: 33619914
[TBL] [Abstract][Full Text] [Related]
6. Contrasting Autoimmune Comorbidities in Microscopic Colitis and Inflammatory Bowel Diseases.
Fedor I; Zold E; Barta Z
Life (Basel); 2023 Feb; 13(3):. PubMed ID: 36983808
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcomes of cancer patients with pre-existing microscopic colitis after exposure to PD-1 and PD-L1 inhibitors.
Thomas AR; Liu C; Tong YT; Tan D; Altan M; Siddiqui BA; Shatila M; Khan A; Thomas AS; Wang Y
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5429-5436. PubMed ID: 36451045
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and Management of Microscopic Colitis in Pediatric Patients.
Khushal S; Oliva-Hemker M
Paediatr Drugs; 2022 May; 24(3):217-233. PubMed ID: 35501559
[TBL] [Abstract][Full Text] [Related]
9. Current Status and Future Therapeutic Options for Fecal Microbiota Transplantation.
Tkach S; Dorofeyev A; Kuzenko I; Boyko N; Falalyeyeva T; Boccuto L; Scarpellini E; Kobyliak N; Abenavoli L
Medicina (Kaunas); 2022 Jan; 58(1):. PubMed ID: 35056392
[TBL] [Abstract][Full Text] [Related]
10. Controversials of Microscopic Colitis.
Mihaly E; Patai Á; Tulassay Z
Front Med (Lausanne); 2021; 8():717438. PubMed ID: 34712675
[TBL] [Abstract][Full Text] [Related]
11. Microscopic colitis.
Burke KE; D'Amato M; Ng SC; Pardi DS; Ludvigsson JF; Khalili H
Nat Rev Dis Primers; 2021 Jun; 7(1):39. PubMed ID: 34112810
[TBL] [Abstract][Full Text] [Related]
12. Faecal microbiota transfer in patients with microscopic colitis - a pilot study in collagenous colitis.
Holster S; Rode J; Bohr J; Kumawat AK; Veress G; Hultgren Hörnquist E; Brummer RJ; König J
Scand J Gastroenterol; 2020 Dec; 55(12):1454-1466. PubMed ID: 33142068
[TBL] [Abstract][Full Text] [Related]
13. Clinical and immunologic effects of faecal microbiota transplantation in a patient with collagenous colitis.
Günaltay S; Rademacher L; Hultgren Hörnquist E; Bohr J
World J Gastroenterol; 2017 Feb; 23(7):1319-1324. PubMed ID: 28275312
[TBL] [Abstract][Full Text] [Related]
14. Multidonor FMT capsules improve symptoms and decrease fecal calprotectin in ulcerative colitis patients while treated - an open-label pilot study.
Cold F; Browne PD; Günther S; Halkjaer SI; Petersen AM; Al-Gibouri Z; Hansen LH; Christensen AH
Scand J Gastroenterol; 2019 Mar; 54(3):289-296. PubMed ID: 30946615
[No Abstract] [Full Text] [Related]
15. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.
Paramsothy S; Kamm MA; Kaakoush NO; Walsh AJ; van den Bogaerde J; Samuel D; Leong RWL; Connor S; Ng W; Paramsothy R; Xuan W; Lin E; Mitchell HM; Borody TJ
Lancet; 2017 Mar; 389(10075):1218-1228. PubMed ID: 28214091
[TBL] [Abstract][Full Text] [Related]
16. Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis.
Costello SP; Soo W; Bryant RV; Jairath V; Hart AL; Andrews JM
Aliment Pharmacol Ther; 2017 Aug; 46(3):213-224. PubMed ID: 28612983
[TBL] [Abstract][Full Text] [Related]
17. Fecal microbiota transplantation in ulcerative colitis.
Blanchaert C; Strubbe B; Peeters H
Acta Gastroenterol Belg; 2019; 82(4):519-528. PubMed ID: 31950808
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
